http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104507953-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-61 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K1-145 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-755 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K1-20 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-14 |
filingDate | 2013-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2018-05-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2018-05-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-104507953-B |
titleOfInvention | The method for handling to reduce protein in protein formulation-pollutant compound and aggregation level by using electropositive organic additive |
abstract | The method that aggregation level in antibody and other protein formulations is reduced by the processing of the combination of the electropositive organic additive (such as Ethacridine, Chlorhexidine or polyethyleneimine) with low concentration and uride (such as urea, uric acid or allantoin) or organic regulator (such as Non-ionic organic polymeric, surfactant, organic solvent or uride).The some aspects of the present invention are related to the aggregation level for reducing cell culture cutting and make its clear method.It further relates to integrate these abilities and other purification process, to reach desired final level of purification. |
priorityDate | 2012-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 122.